Article info
Tuberculosis
Original research
High-dose rifamycins in the treatment of TB: a systematic review and meta-analysis
- Correspondence to Dr James C Johnston, Division of TB Control, BCCDC, Vancouver, BC V5Z 4R4, Canada; james.johnston{at}bccdc.ca
Citation
High-dose rifamycins in the treatment of TB: a systematic review and meta-analysis
Publication history
- Received November 2, 2020
- Accepted December 2, 2021
- First published January 7, 2022.
Online issue publication
November 15, 2022
Article Versions
- Previous version (7 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.